Lobbying
Ari Emanuel: Did he mention lobbying the President or the Vice President?
Submitted by James Love on 15. March 2010 - 12:55See update at the end. ----------
Medical professional and patient group funding by drug and medical device companies
Submitted by James Love on 13. March 2010 - 12:122010
- Ed Silverman, India Proposes Punishment For Docs Who Take Gifts, Pharmalot, March 15, 2010.
- Will state medical councils wield the scalpel,Business Standard, March 15, 2010.
Jeffrey Kindler rewarded by Pfizer for his influence with governments
Submitted by KEI Staff on 9. March 2010 - 14:42On July 28, 2006, Jeffrey Kindler replaced Hank McKinnell as CEO of Pfizer. That day the Pfizer stock price closed at $26.11. With the stock trading today at a little more than $17, it would seem that shareholders have lost a significant amount of their investment. Nonetheless, Kindler is doing well.
PhRMA's revolving door
The following are a few notes on PhRMA's revolving door with the federal government.
Billy Tauzin. Former member of Congress from Louisiana.
Chris Singer. Previously served as a professional staff member for the U.S. House Appropriations Committee.
Brian Toohey. Former Desk Officer and Deputy Director in the European Office of the U.S. Department of Commerce.
Billy Tauzin's 2008 compensation from PhRMA was $4,476,157
Submitted by KEI Staff on 12. February 2010 - 17:12Billy Tauzin announced today that he will be stepping down as President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of June 2010.
PhRMA's 990 Tax Return Form, Schedule J-1 shows the amount Tauzin was compensated in 2008:
Base compensation: $2,055,445
Bonus & incentive compensation: $692,875
Other reportable compensation: $159,412
Deferred compensation: $1,556,960
Nontaxable benefits: $11,465
Total: $4,476,157
PhRMA's grants to US organizations in 2008
Submitted by KEI Staff on 4. February 2010 - 18:31In the United States, tax exempt non-profit organizations are subject some some requirements for financial disclosure via the IRS form 990, which is available to the public. The disclosure requirements cover most U.S. based trade associations, including the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade association for some 28 "member" companies.
Corporate sponsors of the George Institute
Submitted by thiru on 18. January 2010 - 7:45As the 126th session of the Executive Board (EB) of the World Health Organization unfolds today, it appears that the EB will consider agenda item 4.3 on Public health, innovation and intellectual property: Global strategy and plan of action. Under scrutiny will be the work of the Expert Working Group on research and development financing which is mandated by resolution WHA61.21
Roger Bate: Eclectic booster of corporate views
Submitted by thiru on 20. October 2009 - 16:39The Wellcome Trust convened an "Opinion Formers Conference" on "Counterfeit Medicines: Perspectives and Action" on Monday 26 October 2009. The speakers at this meeting included Dr Hans Hogerzeil, Director of Essential Medicines
NYT: PhRMA to support Baucus version of health bill
Submitted by James Love on 13. September 2009 - 8:03According to a report by Duff Wilson in the Sunday New York Times, Much of PhRMA's $150 million in advertising will be spent pushing Senator Baucus's version of the health "reform" legislation.
New York Times reports drug companies pressured DLA Piper to fire Dick Armey
Submitted by James Love on 15. August 2009 - 9:19According to this August 15 report in the New York Times by David Kirkpatrick, drug companies pressed DLA Piper to fire Dick Armey, because Freedom Works, a group chaired by Dick Armey, was opposing the health reform legislation that PhRMA now backs.
